- Open Access
Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
© The Author(s). 2018
- Received: 2 July 2018
- Accepted: 29 August 2018
- Published: 7 October 2018
The original article was published in Stem Cell Research & Therapy 2018 9:15
In Fig. 1a of the original article, FGF10 concentration should be 50 ng/ml – as correctly stated in the Methods section – instead of 100 μg/ml.
Also in Fig. 1a of the original article, Activin A and EGF concentrations should both be 100 ng/ml – as correctly stated in the Methods section – instead of 100 μg/ml.
In the Methods section under the sub-heading “Differentiation of human pluripotent stem cells into pancreatic progenitor”, the term, ‘50 ng/ml hFGF10’ should be omitted from the following sentence:
“At the end of stage 3, media were changed to DMEM supplemented with 1% vol/vol B27, 0.25 mM vitamin C, 50 ng/ml hFGF10, 50 ng/ml hNOGGIN, 100 ng/ml hEGF, and 10 mM nicotinamide (Sigma, USA) for 4 days of stage 4 treatment for each protocol (Fig. 1a).”
FGF10 was only added during stages 2 & 3 of differentiation as correctly depicted in Fig. 1a.
The corrected version of Fig. 1a can be viewed ahead.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.